Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,339 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $733.60 | 6 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $242.86 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $237.86 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.81 | 1 | Teva Pharmaceuticals USA, Inc. ($124.81) |
| 2023 | $122.06 | 1 | Otsuka America Pharmaceutical, Inc. ($122.06) |
| 2021 | $249.69 | 2 | Alkermes, Inc. ($249.69) |
| 2019 | $113.92 | 1 | Alkermes, Inc. ($113.92) |
| 2018 | $608.84 | 5 | Alkermes, Inc. ($249.99) |
| 2017 | $120.00 | 1 | Alkermes, Inc. ($120.00) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: Neurology | ||||||
| 07/06/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/15/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 11/09/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $124.69 | General |
| Category: CNS | ||||||
| 06/11/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $113.92 | General |
| Category: CNS | ||||||
| 11/06/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: CNS | ||||||
| 09/20/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 07/24/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 07/12/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $113.05 | General |
| Category: Central Nervous System | ||||||
| 06/26/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 71 | 198 | $48,365 | $20,336 |
| 2022 | 3 | 65 | 177 | $59,857 | $15,374 |
| 2021 | 4 | 119 | 261 | $90,933 | $22,921 |
| 2020 | 3 | 67 | 167 | $53,161 | $14,203 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 158 | $35,565 | $15,606 | 43.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 19 | $8,075 | $2,734 | 33.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 21 | $4,725 | $1,996 | 42.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 145 | $45,674 | $11,709 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $8,504 | $2,297 | 27.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 18 | $5,679 | $1,368 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 57 | 178 | $58,028 | $14,844 | 25.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $18,560 | $4,347 | 23.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 35 | $7,980 | $2,072 | 26.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 19 | 19 | $6,365 | $1,659 | 26.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 131 | $42,706 | $11,421 | 26.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 21 | 21 | $7,035 | $1,874 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 15 | $3,420 | $907.50 | 26.5% |
About Ibrahim Sablaban
Ibrahim Sablaban is a Pharmacist healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1831553528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ibrahim Sablaban has received a total of $1,339 in payments from pharmaceutical and medical device companies, with $124.81 received in 2024. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,339).
As a Medicare-enrolled provider, Sablaban has provided services to 322 Medicare beneficiaries, totaling 803 services with total Medicare billing of $72,834. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Pharmacist
- Other Specialties Addiction Medicine, Psychiatry
- Location Detroit, MI
- Active Since 04/08/2016
- Last Updated 03/06/2023
- Taxonomy Code 183500000X
- Entity Type Individual
- NPI Number 1831553528
Products in Payments
- Aristada 441 mg (Drug) $369.99
- LYBALVI (Drug) $249.69
- LATUDA (Drug) $125.00
- UZEDY (Drug) $124.81
- ABILIFY ASIMTUFII (Drug) $122.06
- REXULTI (Drug) $120.80
- ARISTADA (Drug) $113.92
- AUSTEDO (Drug) $113.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pharmacist Doctors in Detroit
Yousef Maaz
Pharmacist — Payments: $601.20
Mr. Barry Sternberg, Rph, RPH
Pharmacist
Mr. Andrew Sternberg, Rph, RPH
Pharmacist
Mrs. Kim Binion Richards, Rph, Mba, RPH, MBA
Pharmacist
Dr. Roseanne Paglia, Pharm.d, PHARM.D
Pharmacist
Irwin Rabinowitz, Rph, RPH
Pharmacist